Transcept Pharmaceuticals Announces That Largest Stockholder, Roumell Asset Management, Declares Support Of Company Strategies

Company also announces the appointment of Matthew M. Loar to the Transcept Board of Directors

Dec 16, 2013, 22:45 ET from Transcept Pharmaceuticals, Inc.

$countyNameToPathMap.put("sp